Filter results
You can narrow down the results using the filters
For more information please visit the Australian prescription medicine decision summaries information page.
Search
162 result(s) found, displaying 1 to 25
- Prescription medicine decision summaryRadicavaTGA decision: Radicava (edaravone) is approved to treat adults with a diagnosis of amyotrophic lateral sclerosis.
- Prescription medicine decision summarySpikevax bivalent Original/Omicron BA.4-5approved to prevent coronavirus disease 2019 (COVID-19)
- Prescription medicine decision summaryNuceivaNuceiva (prabotulinumtoxinA) is approved to treat glabellar lines.
- Prescription medicine decision summaryDopteletDoptelet (avatrombopag maleate) is approved to treat thrombocytopenia in adult patients.
- Prescription medicine decision summaryComirnaty Original/Omicron BA.4-5 COVID-19 vaccineComirnaty Original/Omicron BA.4-5 COVID-19 vaccine (tozinameran and famtozinameran) is approved to prevent coronavirus disease 2019.
- Prescription medicine decision summaryMounjaroMounjaro (tirzepatide) is approved to treat diabetes.
- Prescription medicine decision summaryWeliregWelireg (belzutifan) is approved to treat adult patients with von Hippel-Lindau (VHL) disease
- Prescription medicine decision summaryEvusheldEvusheld (tixagevimab and cilgavimab) is approved to treat COVID-19
- Prescription medicine decision summaryRybrevantTGA decision: Rybrevant (amivantamab) is approved to treat lung cancer
- Prescription medicine decision summaryPrevenar 20TGA decision: Prevenar 20 (Pneumococcal purified capsular polysaccharides) is approved to prevent pneumococcal disease.
- Prescription medicine decision summarySotyktuSotyktu (deucravacitinib) is approved to treat plaque psoriasis.
- Prescription medicine decision summaryLetyboTGA decision: Letybo (letibotulinumtoxinA) is approved to treat the appearance of moderate to severe glabellar frown lines in adults.
- Prescription medicine decision summaryOnpattroOnpattro (patisiran) is approved to treat polyneuropathy.
- Prescription medicine decision summaryKorsuvaKorsuva (difelikefalin acetate) is approved to treat chronic kidney disease
- Prescription medicine decision summaryVazkepaVazkepa (Icosapent ethyl) is approved to treat cardiovascular disease.
- Prescription medicine decision summaryVabysmoVabysmo (faricimab) is approved to treat macular degeneration.
- Prescription medicine decision summaryComirnaty original/Omicron BA.1 COVID-19 VaccineComirnaty original/Omicron BA.1 COVID-19 Vaccine (Tozinameran and riltozinameran) is provisionally approved to treat COVID-19.
- Prescription medicine decision summaryVerorabVerorab (inactivated rabies virus) is approved to treat rabies.
- Prescription medicine decision summaryLivtencityLivtencity (maribavir) is approved to treat cytomegalovirus (CMV).
- Prescription medicine decision summaryCamzyosCamzyos (mavacamten) is approved to treat cardiomyopathy.
- Prescription medicine decision summaryXembifyTGA decision: Xembify (normal immunoglobulin human) is approved to treat primary immunodeficiency diseases (PID).
- Prescription medicine decision summaryPadcevPadcev (enfortumab vedotin) is approved to treat adult patients with locally advanced or metastatic urothelial cancer.
- Prescription medicine decision summaryScemblixScemblix (asciminib) is approved to treat Philadelphia chromosome-positive chronic myeloid leukaemia.
- Prescription medicine decision summaryTrastucip and TuzucipTGA decision: Trastucip and Tuzucip (trastuzumab) are approved to treat breast cancer.
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Next page Next ›
- Last page Last »